{"transactions":[{"id":1237158,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Common Stock","published_at":"2025-03-03T11:01:06.000Z","date":"2025-02-27","kind":"purchase","planned":false,"acquired":true,"shares":12500,"price":1.765,"value":22062.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents the open market purchase of 12,500 shares at an executed price of $1.765 per share."}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0000950170-25-030329","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000095017025030329/ownership.xml","form_type":"4"}},{"id":1257191,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Restricted Stock Units","published_at":"2025-02-20T21:05:08.000Z","date":"2025-02-18","kind":"grant","planned":false,"acquired":true,"shares":410000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on February 18, 2025 and vest in four consecutive equal annual installments from the date of grant, provided the Reporting Person continues to provide services to the Issuer through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on February 18, 2025 and vest in four consecutive equal annual installments from the date of grant, provided the Reporting Person continues to provide services to the Issuer through the applicable vesting date."}],"balance_after":410000,"derivative":{"underlying":"Common Stock","underlying_shares":410000},"source":{"system":"sec-edgar","filing":"0000950170-25-024132","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886744/000095017025024132/ownership.xml","form_type":"4"}},{"id":1257190,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-20T21:05:08.000Z","date":"2025-02-18","kind":"grant","planned":false,"acquired":true,"shares":2457000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 18, 2025 and vests in 48 consecutive equal monthly installments from the date of grant, provided the Reporting Person continues to provide services to the Issuer through the applicable vesting date."}],"balance_after":2457000,"derivative":{"exercise_price":2.63,"expiration_date":"2035-02-17","underlying":"Common Stock","underlying_shares":2457000},"source":{"system":"sec-edgar","filing":"0000950170-25-024132","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000095017025024132/ownership.xml","form_type":"4"}},{"id":1487614,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-06-07T20:10:06.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Performance-based stock option granted on November 7, 2018 and vested in full on June 6, 2024 upon approval by the US FDA for imetelstat in lower risk MDS."}],"balance_after":1000000,"derivative":{"exercise_price":1.72,"expiration_date":"2028-11-06","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0000950170-24-070625","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000095017024070625/ownership.xml","form_type":"4"}},{"id":1490882,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-05T20:05:20.000Z","date":"2024-06-04","kind":"exercise","planned":false,"acquired":false,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction reflects an exercise and sale of options due to expire on February 11, 2026 and was conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on February 20, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.54,"expiration_date":"2026-02-11","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0000950170-24-069289","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886744/000095017024069289/ownership.xml","form_type":"4"}},{"id":1490881,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Common Stock","published_at":"2024-06-05T20:05:20.000Z","date":"2024-06-04","kind":"sale","planned":false,"acquired":false,"shares":600000,"price":4,"value":2400000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction reflects an exercise and sale of options due to expire on February 11, 2026 and was conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on February 20, 2024."}],"balance_after":600000,"source":{"system":"sec-edgar","filing":"0000950170-24-069289","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886744/000095017024069289/ownership.xml","form_type":"4"}},{"id":1490880,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Common Stock","published_at":"2024-06-05T20:05:20.000Z","date":"2024-06-04","kind":"exercise","planned":false,"acquired":true,"shares":600000,"price":2.54,"value":1524000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction reflects an exercise and sale of options due to expire on February 11, 2026 and was conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on February 20, 2024."}],"balance_after":600000,"source":{"system":"sec-edgar","filing":"0000950170-24-069289","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000095017024069289/ownership.xml","form_type":"4"}},{"id":1639457,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, PRESIDENT AND CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-16T21:06:08.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":3000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in a series of 48 consecutive equal monthly installments commencing February 14, 2024, provided the optionee continues to provide service to the Company."}],"balance_after":3000000,"derivative":{"exercise_price":2.1,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":3000000},"source":{"system":"sec-edgar","filing":"0001415889-24-004094","document":"form4-02162024_090200.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000141588924004094/form4-02162024_090200.xml","form_type":"4"}},{"id":1775835,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2023-09-22T00:32:38.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Performance-based stock option granted on November 7, 2018 and vested in full on August 15, 2023 upon acceptance of the NDA by the\nUS FDA for imetelstat in lower risk MDS."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Performance-based stock option granted on November 7, 2018 and vested in full on August 15, 2023 upon acceptance of the NDA by the\nUS FDA for imetelstat in lower risk MDS."}],"balance_after":500000,"derivative":{"exercise_price":1.72,"exercise_date":"2023-08-15","expiration_date":"2028-11-06","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001062993-23-018393","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323018393/form4.xml","form_type":"4"}},{"id":1994376,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2023-02-25T00:16:38.000Z","date":"2023-02-22","kind":"grant","acquired":true,"shares":1750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in a series of 48 consecutive equal monthly installments commencing February 22, 2023, provided the optionee continues to provide service to the Company."}],"balance_after":1750000,"derivative":{"exercise_price":2.83,"expiration_date":"2033-02-21","underlying":"Common Stock","underlying_shares":1750000},"source":{"system":"sec-edgar","filing":"0001062993-23-004898","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323004898/form4.xml","form_type":"4"}},{"id":2023596,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-11T02:47:40.000Z","date":"2023-02-10","kind":"exercise","acquired":false,"shares":446668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These transactions reflect exercises and sales of options due to expire on February 13, 2023 and were conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on January 9, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.5,"expiration_date":"2023-02-13","underlying":"Common Stock","underlying_shares":446668},"source":{"system":"sec-edgar","filing":"0001062993-23-002790","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323002790/form4.xml","form_type":"4"}},{"id":2023595,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-11T02:47:40.000Z","date":"2023-02-09","kind":"exercise","acquired":false,"shares":446666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These transactions reflect exercises and sales of options due to expire on February 13, 2023 and were conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on January 9, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.5,"expiration_date":"2023-02-13","underlying":"Common Stock","underlying_shares":446666},"source":{"system":"sec-edgar","filing":"0001062993-23-002790","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323002790/form4.xml","form_type":"4"}},{"id":2023594,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-11T02:47:40.000Z","date":"2023-02-08","kind":"exercise","acquired":false,"shares":446666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These transactions reflect exercises and sales of options due to expire on February 13, 2023 and were conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on January 9, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.5,"expiration_date":"2023-02-13","underlying":"Common Stock","underlying_shares":446666},"source":{"system":"sec-edgar","filing":"0001062993-23-002790","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323002790/form4.xml","form_type":"4"}},{"id":2023593,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Common Stock","published_at":"2023-02-11T02:47:40.000Z","date":"2023-02-10","kind":"sale","acquired":false,"shares":446668,"price":3,"value":1340004.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These transactions reflect exercises and sales of options due to expire on February 13, 2023 and were conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on January 9, 2023."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001062993-23-002790","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323002790/form4.xml","form_type":"4"}},{"id":2023592,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Common Stock","published_at":"2023-02-11T02:47:40.000Z","date":"2023-02-10","kind":"exercise","acquired":true,"shares":446668,"price":1.5,"value":670002.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These transactions reflect exercises and sales of options due to expire on February 13, 2023 and were conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on January 9, 2023."}],"balance_after":446668,"source":{"system":"sec-edgar","filing":"0001062993-23-002790","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323002790/form4.xml","form_type":"4"}},{"id":2023591,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Common Stock","published_at":"2023-02-11T02:47:40.000Z","date":"2023-02-09","kind":"sale","acquired":false,"shares":446666,"price":3.03,"value":1353397.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These transactions reflect exercises and sales of options due to expire on February 13, 2023 and were conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on January 9, 2023."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001062993-23-002790","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323002790/form4.xml","form_type":"4"}},{"id":2023590,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Common Stock","published_at":"2023-02-11T02:47:40.000Z","date":"2023-02-09","kind":"exercise","acquired":true,"shares":446666,"price":1.5,"value":669999.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These transactions reflect exercises and sales of options due to expire on February 13, 2023 and were conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on January 9, 2023."}],"balance_after":446666,"source":{"system":"sec-edgar","filing":"0001062993-23-002790","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323002790/form4.xml","form_type":"4"}},{"id":2023589,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Common Stock","published_at":"2023-02-11T02:47:40.000Z","date":"2023-02-08","kind":"sale","acquired":false,"shares":446666,"price":3.08,"value":1375731.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These transactions reflect exercises and sales of options due to expire on February 13, 2023 and were conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on January 9, 2023."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001062993-23-002790","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323002790/form4.xml","form_type":"4"}},{"id":2023588,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Common Stock","published_at":"2023-02-11T02:47:40.000Z","date":"2023-02-08","kind":"exercise","acquired":true,"shares":446666,"price":1.5,"value":669999.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These transactions reflect exercises and sales of options due to expire on February 13, 2023 and were conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on January 9, 2023."}],"balance_after":446666,"source":{"system":"sec-edgar","filing":"0001062993-23-002790","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299323002790/form4.xml","form_type":"4"}},{"id":2386469,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2022-02-18T23:03:59.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":2100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in a series of 48 consecutive equal monthly installments commencing February 16, 2022, provided the optionee continues to provide service to the Company."}],"balance_after":2100000,"derivative":{"exercise_price":1.06,"expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":2100000},"source":{"system":"sec-edgar","filing":"0001062993-22-005003","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000106299322005003/form4.xml","form_type":"4"}},{"id":2612807,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T17:57:28.000Z","date":"2021-08-05","kind":"disposition_to_issuer","acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of May 4, 2021, by and among Chiasma, Inc. (the \"Company), Amryt Pharma plc (\"Parent\"), and Acorn Merger Sub, Inc., an indirect wholly-owned subsidiary of Parent (\"Merger Sub\") pursuant to which Merger Sub merged with and into the Company (the \"Merger\") with the Company surviving as an indirect wholly owned subsidiary of Parent effective as of August [5], 2021 (the \"Effective Time\")."},{"field":"kind","element":"transactionCoding","label":"F3","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":5.81,"underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-21-050037","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1270928/000120919121050037/doc4.xml","form_type":"4"}},{"id":2612806,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T17:57:28.000Z","date":"2021-08-05","kind":"disposition_to_issuer","acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of May 4, 2021, by and among Chiasma, Inc. (the \"Company), Amryt Pharma plc (\"Parent\"), and Acorn Merger Sub, Inc., an indirect wholly-owned subsidiary of Parent (\"Merger Sub\") pursuant to which Merger Sub merged with and into the Company (the \"Merger\") with the Company surviving as an indirect wholly owned subsidiary of Parent effective as of August [5], 2021 (the \"Effective Time\")."},{"field":"kind","element":"transactionCoding","label":"F3","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":7.98,"underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-21-050037","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1270928/000120919121050037/doc4.xml","form_type":"4"}},{"id":2612805,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T17:57:28.000Z","date":"2021-08-05","kind":"disposition_to_issuer","acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of May 4, 2021, by and among Chiasma, Inc. (the \"Company), Amryt Pharma plc (\"Parent\"), and Acorn Merger Sub, Inc., an indirect wholly-owned subsidiary of Parent (\"Merger Sub\") pursuant to which Merger Sub merged with and into the Company (the \"Merger\") with the Company surviving as an indirect wholly owned subsidiary of Parent effective as of August [5], 2021 (the \"Effective Time\")."},{"field":"kind","element":"transactionCoding","label":"F3","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":1.45,"underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-21-050037","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1270928/000120919121050037/doc4.xml","form_type":"4"}},{"id":2612804,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T17:57:28.000Z","date":"2021-08-05","kind":"disposition_to_issuer","acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of May 4, 2021, by and among Chiasma, Inc. (the \"Company), Amryt Pharma plc (\"Parent\"), and Acorn Merger Sub, Inc., an indirect wholly-owned subsidiary of Parent (\"Merger Sub\") pursuant to which Merger Sub merged with and into the Company (the \"Merger\") with the Company surviving as an indirect wholly owned subsidiary of Parent effective as of August [5], 2021 (the \"Effective Time\")."},{"field":"kind","element":"transactionCoding","label":"F3","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":1.35,"underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-21-050037","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1270928/000120919121050037/doc4.xml","form_type":"4"}},{"id":2612803,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T17:57:28.000Z","date":"2021-08-05","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of May 4, 2021, by and among Chiasma, Inc. (the \"Company), Amryt Pharma plc (\"Parent\"), and Acorn Merger Sub, Inc., an indirect wholly-owned subsidiary of Parent (\"Merger Sub\") pursuant to which Merger Sub merged with and into the Company (the \"Merger\") with the Company surviving as an indirect wholly owned subsidiary of Parent effective as of August [5], 2021 (the \"Effective Time\")."},{"field":"kind","element":"transactionCoding","label":"F3","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"At the Effective Time, each option to purchase Shares (each a \"Company Option\") that was outstanding and unexercised, immediately prior to the Effective Time, whether or not vested shall, by virtue of the Merger Agreement, ceased to represent a right to acquire Shares, was assumed by Parent and automatically converted into the option to purchase Parent ADSs (each an \"Assumed Stock Option\") shall be equal to (i) the number of Shares subject to each Company Option immediately prior to the Effective Time multiplied by (ii) the Exchange Ratio, rounded down, if necessary, to the nearest whole number of Parent ADSs, and such Assumed Stock Option shall have an exercise price per Parent ADS (rounded up to the nearest cent) equal to (a) the exercise price per Share otherwise purchasable pursuant to such Company Option divided by (b) the Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":3.14,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-050037","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270928/000120919121050037/doc4.xml","form_type":"4"}},{"id":2612802,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-05T17:57:28.000Z","date":"2021-08-05","kind":"disposition_to_issuer","acquired":false,"shares":61322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\") dated as of May 4, 2021, by and among Chiasma, Inc. (the \"Company), Amryt Pharma plc (\"Parent\"), and Acorn Merger Sub, Inc., an indirect wholly-owned subsidiary of Parent (\"Merger Sub\") pursuant to which Merger Sub merged with and into the Company (the \"Merger\") with the Company surviving as an indirect wholly owned subsidiary of Parent effective as of August [5], 2021 (the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each issued and outstanding share of common stock of the Company (each, a \"Share\") (excluding any Shares held in the treasury of the Company or owned, directly or indirectly, by Parent or Merger Sub immediately prior to the Effective Time) was cancelled and converted into the right to receive 0.396 (the \"Exchange Ratio\") American Depositary Shares of Parent (\"Parent ADS\") representing five Ordinary Shares of Parent."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-050037","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270928/000120919121050037/doc4.xml","form_type":"4"}},{"id":2663273,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T18:46:39.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":7.13,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001567619-21-012369","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270928/000156761921012369/doc1.xml","form_type":"4"}},{"id":2879778,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2021-02-05T00:44:31.000Z","date":"2021-02-02","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in a series of 48 consecutive equal monthly installments commencing February 2, 2021, provided the optionee continues to provide service to the Company."}],"balance_after":600000,"derivative":{"exercise_price":2.055,"expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0000886744-21-000015","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674421000015/edgar.xml","form_type":"4"}},{"id":3105245,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-18T15:01:07.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2021 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":8.35,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001567619-20-012361","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270928/000156761920012361/doc1.xml","form_type":"4"}},{"id":3111606,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-12T20:27:01.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Common Stock underlying the option will vest upon the earlier of (i) June 11, 2021 or the (ii) the date of the issuer's next annual meeting of the stockholders."}],"balance_after":13000,"derivative":{"exercise_price":5.81,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-20-036471","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270928/000120919120036471/doc4.xml","form_type":"4"}},{"id":3272039,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-02-15T00:38:02.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":582750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in a series of 48 consecutive equal monthly installments commencing February 12, 2020 provided the optionee continues to provide services to the Company."}],"balance_after":582750,"derivative":{"exercise_price":1.295,"expiration_date":"2030-02-11","underlying":"Common Stock","underlying_shares":582750},"source":{"system":"sec-edgar","filing":"0000886744-20-000026","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674420000026/edgar.xml","form_type":"4"}},{"id":3481153,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-21T14:06:53.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2020 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":14000,"derivative":{"exercise_price":11.31,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001567619-19-013827","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270928/000156761919013827/doc1.xml","form_type":"4"}},{"id":3487534,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-17T18:53:41.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Common Stock underlying the option will vest upon the earlier of (1) June 13, 2020 and (ii) the date of the issuer's next annual meeting of the stockholders."}],"balance_after":13000,"derivative":{"exercise_price":7.98,"expiration_date":"2029-06-13","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-19-037505","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270928/000120919119037505/doc4.xml","form_type":"4"}},{"id":3680339,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Chairman"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-02-01T23:58:09.000Z","date":"2019-01-30","kind":"grant","acquired":true,"shares":1050000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in a series of 48 consecutive equal monthly installments commencing January 30, 2019 provided the optionee continues to provide services to the Company."}],"balance_after":1050000,"derivative":{"exercise_price":1.03,"expiration_date":"2029-01-29","underlying":"Common Stock","underlying_shares":1050000},"source":{"system":"sec-edgar","filing":"0000886744-19-000022","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674419000022/edgar.xml","form_type":"4"}},{"id":3892276,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-15T17:47:12.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2019 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":14000,"derivative":{"exercise_price":25.25,"expiration_date":"2028-06-12","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0000899243-18-016814","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270928/000089924318016814/doc4.xml","form_type":"4"}},{"id":3898222,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-11T16:22:15.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock Option granted in accordance with the Issuer's Non-Employee Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock underlying the option will vest upon the earlier of (1) June 7, 2019 and (ii) the date of the Issuer's 2019 annual meeting of the stockholders."}],"balance_after":13000,"derivative":{"exercise_price":1.45,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-18-036944","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270928/000120919118036944/doc4.xml","form_type":"4"}},{"id":4080226,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-02-02T23:10:53.000Z","date":"2018-01-31","kind":"grant","acquired":true,"shares":1050000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in a series of 48 consecutive equal monthly installments commencing January 31, 2018 provided the optionee continues to provide services to the Company."}],"balance_after":1050000,"derivative":{"exercise_price":2.45,"expiration_date":"2028-01-31","underlying":"Common Stock","underlying_shares":1050000},"source":{"system":"sec-edgar","filing":"0000886744-18-000018","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674418000018/edgar.xml","form_type":"4"}},{"id":4274413,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-22T13:57:41.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on June 20, 2018 subject to the Reporting Person's continued service to the Issuer through such date."}],"balance_after":14000,"derivative":{"exercise_price":13.78,"expiration_date":"2027-06-19","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001140361-17-025788","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270928/000114036117025788/doc1.xml","form_type":"4"}},{"id":4277287,"issuer":{"id":136487,"kind":"organization","name":"CHIASMA, INC","symbol":"CHMA"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-19T16:04:23.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Stock Option granted in accordance with the Issuer's Non-Employee Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock underlying the option will vest upon the earlier of (1) June 15, 2018 and (ii) the date of the Issuer's 2018 annual meeting of the stockholders."}],"balance_after":13000,"derivative":{"exercise_price":1.35,"expiration_date":"2027-06-15","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-17-040782","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270928/000120919117040782/doc4.xml","form_type":"4"}},{"id":4458065,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":82643,"kind":"person","name":"SCARLETT JOHN A","position":1,"cik":"0001270928","reported_name":"SCARLETT JOHN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-02-11T01:15:52.000Z","date":"2017-02-09","kind":"grant","acquired":true,"shares":1050000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in a series of 48 consecutive equal monthly installments commencing February 9, 2017 provided the optionee continues to provide services to the Company."}],"balance_after":1050000,"derivative":{"exercise_price":2.15,"expiration_date":"2027-02-09","underlying":"Common Stock","underlying_shares":1050000},"source":{"system":"sec-edgar","filing":"0000886744-17-000012","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000088674417000012/edgar.xml","form_type":"4"}}]}